RT @cardiomet_CE
1) Welcome to a new #accredited #tweetorial on the latest advances in the management of #CKD in the setting of patients with and without #T2D—with one more update from #ASN22 #KIDNEYWEEK2022 and #AHA22 and the results of the #EMPA_KIDNEY trial.
#accredited #tweetorial #CKD #T2D #asn22 #kidneyweek2022 #AHA22 #empa_kidney